These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 34973363)

  • 1. Thioredoxin reductase 1 inhibitor shikonin promotes cell necroptosis via SecTRAPs generation and oxygen-coupled redox cycling.
    Zhang Y; Sun S; Xu W; Yang R; Yang Y; Guo J; Ma K; Xu J
    Free Radic Biol Med; 2022 Feb; 180():52-62. PubMed ID: 34973363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plumbagin reduction by thioredoxin reductase 1 possesses synergy effects with GLUT1 inhibitor on KEAP1-mutant NSCLC cells.
    Sun S; Zhang Y; Xu W; Yang R; Yang Y; Guo J; Ma Q; Ma K; Zhang J; Xu J
    Biomed Pharmacother; 2022 Feb; 146():112546. PubMed ID: 34954641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of TXNRD or SOD1 overcomes NRF2-mediated resistance to β-lapachone.
    Torrente L; Prieto-Farigua N; Falzone A; Elkins CM; Boothman DA; Haura EB; DeNicola GM
    Redox Biol; 2020 Feb; 30():101440. PubMed ID: 32007910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shikonin targets cytosolic thioredoxin reductase to induce ROS-mediated apoptosis in human promyelocytic leukemia HL-60 cells.
    Duan D; Zhang B; Yao J; Liu Y; Fang J
    Free Radic Biol Med; 2014 May; 70():182-93. PubMed ID: 24583460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necroptosis inhibits autophagy by regulating the formation of RIP3/p62/Keap1 complex in shikonin-induced ROS dependent cell death of human bladder cancer.
    Liu X; Liu L; Wang X; Jin Y; Wang S; Xie Q; Jin Y; Zhang M; Liu Y; Li J; Wang Z; Fu X; Jin CY
    Phytomedicine; 2023 Sep; 118():154943. PubMed ID: 37421765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thioredoxin reductase-1 levels are associated with NRF2 pathway activation and tumor recurrence in non-small cell lung cancer.
    Delgobo M; Gonçalves RM; Delazeri MA; Falchetti M; Zandoná A; Nascimento das Neves R; Almeida K; Fagundes AC; Gelain DP; Fracasso JI; Macêdo GB; Priori L; Bassani N; Bishop AJR; Forcelini CM; Moreira JCF; Zanotto-Filho A
    Free Radic Biol Med; 2021 Dec; 177():58-71. PubMed ID: 34673143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KEAP1-dependent synthetic lethality induced by AKT and TXNRD1 inhibitors in lung cancer.
    Dai B; Yoo SY; Bartholomeusz G; Graham RA; Majidi M; Yan S; Meng J; Ji L; Coombes K; Minna JD; Fang B; Roth JA
    Cancer Res; 2013 Sep; 73(17):5532-43. PubMed ID: 23824739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TrxR1 as a potent regulator of the Nrf2-Keap1 response system.
    Cebula M; Schmidt EE; Arnér ES
    Antioxid Redox Signal; 2015 Oct; 23(10):823-53. PubMed ID: 26058897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway.
    Li X; Fan XX; Jiang ZB; Loo WT; Yao XJ; Leung EL; Chow LW; Liu L
    Pharmacol Res; 2017 Jan; 115():45-55. PubMed ID: 27864022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CRISPR screen identifies redox vulnerabilities for KEAP1/NRF2 mutant non-small cell lung cancer.
    Jiang C; Ward NP; Prieto-Farigua N; Kang YP; Thalakola A; Teng M; DeNicola GM
    Redox Biol; 2022 Aug; 54():102358. PubMed ID: 35667246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menadione inhibits thioredoxin reductase 1 via arylation at the Sec
    Sun S; Xu W; Zhang Y; Yang Y; Ma Q; Xu J
    Free Radic Biol Med; 2021 Aug; 172():482-489. PubMed ID: 34186208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay between cytosolic disulfide reductase systems and the Nrf2/Keap1 pathway.
    Schmidt EE
    Biochem Soc Trans; 2015 Aug; 43(4):632-8. PubMed ID: 26551704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Details in the catalytic mechanism of mammalian thioredoxin reductase 1 revealed using point mutations and juglone-coupled enzyme activities.
    Xu J; Cheng Q; Arnér ES
    Free Radic Biol Med; 2016 May; 94():110-20. PubMed ID: 26898501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The discovery and characterization of K-563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp.
    Hori R; Yamaguchi K; Sato H; Watanabe M; Tsutsumi K; Iwamoto S; Abe M; Onodera H; Nakamura S; Nakai R
    Cancer Med; 2019 Mar; 8(3):1157-1168. PubMed ID: 30735010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox regulation of the NLRP3-mediated inflammation and pyroptosis.
    Rusetskaya NY; Loginova NY; Pokrovskaya EP; Chesovskikh YS; Titova LE
    Biomed Khim; 2023 Dec; 69(6):333-352. PubMed ID: 38153050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Selenium compounds in redox regulation of inflammation and apoptosis].
    Rusetskaya NY; Fedotov IV; Koftina VA; Borodulin VB
    Biomed Khim; 2019 Apr; 65(3):165-179. PubMed ID: 31258141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell death by SecTRAPs: thioredoxin reductase as a prooxidant killer of cells.
    Anestål K; Prast-Nielsen S; Cenas N; Arnér ES
    PLoS One; 2008 Apr; 3(4):e1846. PubMed ID: 18382651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducing ubiquitination and degradation of TrxR1 protein by LW-216 promotes apoptosis in non-small cell lung cancer via triggering ROS production.
    Wang R; Zhong L; Wang T; Sun T; Yang J; Liu X; Wu Y; Guo Q; Gao Y; Zhao K
    Neoplasia; 2024 Jul; 53():101004. PubMed ID: 38733769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thioredoxin Reductase Inhibition for Cancer Therapy.
    Gencheva R; Arnér ESJ
    Annu Rev Pharmacol Toxicol; 2022 Jan; 62():177-196. PubMed ID: 34449246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerobic exercise modulates cardiac NAD(P)H oxidase and the NRF2/KEAP1 pathway in a mouse model of chronic fructose consumption.
    Alves R; Suehiro CL; Oliveira FG; Frantz EDC; Medeiros RF; Vieira RP; Martins MA; Lin CJ; Nobrega ACLD; Toledo-Arruda AC
    J Appl Physiol (1985); 2020 Jan; 128(1):59-69. PubMed ID: 31647720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.